Bellevue Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Bellevue Group's RGEN Position: Q4 2022 in Review
Bellevue Group sold out of Repligen (RGEN) in Q4 2022, closing a stake of 6,600 shares — an estimated $1.24M sold.
Bellevue Group first reported a position in RGEN in Q4 2019 and held it in 3 quarters. The position peaked at $1.31M in Q1 2020. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.
- Bellevue Group reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
- Bellevue Group sold 6,600 Repligen shares in Q4 2022, an estimated $1.24M.
- Bellevue Group first reported a position in Repligen in Q4 2019 and held it in 3 quarters.
- Bellevue Group's Repligen position peaked at $1.31M in Q1 2020.
- 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.
Based on Bellevue Group's 13F filing for Q4 2022, filed 14 Feb 2023.